Medicine and Science from The BMJ
Can a deal be done to keep the US in the WHO?
Jan 24, 2025
Larry Gostin, a Georgetown University Professor of Global Health and director of the WHO Collaborating Center on National and Global Health Law, tackles the implications of the U.S. executive order to withdraw from the WHO. He argues that congressional approval is necessary for the withdrawal, not just an executive order. The discussion covers the WHO’s funding challenges, its relationship with China, and the benefits of U.S. involvement, emphasizing the critical need for reforms and international cooperation in managing global health crises.
29:31
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The U.S. decision to potentially withdraw from the WHO represents a significant shift from its historical role as a key supporter of global health initiatives.
- Reforming WHO and increasing contributions from other nations are seen as more effective solutions than U.S. withdrawal for addressing global health challenges.
Deep dives
Historic Withdrawal from WHO
The United States' decision to withdraw from the World Health Organization (WHO) under the Trump administration is described as a historic and cataclysmic choice. This action marks a significant departure from the U.S.'s longstanding role as a founding member and major supporter of WHO since its establishment in 1948. The implications of this withdrawal not only affect U.S. involvement but also diminish global health initiatives that the organization coordinates. By cutting funding and staff, as well as revoking participation in critical health regulations, the U.S. is diminishing its own influence and potentially allowing other nations, such as China, to take the lead in global health matters.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
